Home > Income Statement > SUVEN PHARMACEUTICALS

SUVEN PHARMACEUTICALS
Revenue

    Back to Income Statement
SUVEN PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for SUVEN PHARMACEUTICALS
Please provide your vote to see the results

SUVEN PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹1,340 Cr₹1,320 Cr₹1,010 Cr₹834 Cr₹378 Cr

What is the latest Revenue of SUVEN PHARMACEUTICALS ?

The latest Revenue ratio of SUVEN PHARMACEUTICALS is ₹1,340 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹1,340 Cr
Mar2023₹1,320 Cr
Mar2022₹1,010 Cr
Mar2021₹834 Cr
Mar2020₹378 Cr

How is Revenue of SUVEN PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2024 ₹1,340 Cr
1.52
Mar2023 ₹1,320 Cr
30.75
Mar2022 ₹1,010 Cr
21.10
Mar2021 ₹834 Cr
120.68
Mar2020 ₹378 Cr -

Compare Revenue of peers of SUVEN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS ₹29,193.7 Cr -7% -2.3% 77.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,910.0 Cr 5.4% 3.2% 20.4% Stock Analytics
DIVIS LABORATORIES ₹160,035.0 Cr 1.9% 2% 59.4% Stock Analytics
CIPLA ₹125,540.0 Cr 1.7% 2% 13.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹112,894.0 Cr 2.8% 2.3% 22.8% Stock Analytics
DR REDDYS LABORATORIES ₹100,110.0 Cr 2.1% -0.9% -1.5% Stock Analytics


SUVEN PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS

-7%

-2.3%

77.6%

SENSEX

1%

4.3%

8.9%


You may also like the below Video Courses